COIOSDeep risk insights through multi-disciplinary research across the globe
beige concrete building
Item confirms Peer-reviewed Added

Kidney cancer mortality fell in Medicaid expansion states, but not for Black patients

Among 284,967 US adults aged 40 to 64 with renal cell carcinoma, overall mortality was 7.5% lower in Medicaid expansion states, with no change in five-year survival for Black patients.

A difference-in-differences analysis of 284,967 adults aged 40 to 64 in the National Cancer Database compared Medicaid expansion states with non-expansion states, 2006 to 2021. Expansion was associated with a 7.5% reduction in overall mortality, and a 1.4 percentage point fall in five-year mortality. The fall in five-year mortality was 6.3 percentage points among Hispanic patients, and not significant among non-Hispanic Black patients.

Why it is interesting: A change in who is insured moved survival at working ages, but not for every group.

Source
Journal of Surgical Research, 22 September 2026
Paper
Medicaid Expansion and Overall Mortality Among Individuals With Renal Cell Carcinoma
Authors
Akinyemi O, Oyebanji O, Fasokun M, Mba-Madubuike I, Singleton D, Hughes K et al.
DOI
10.1016/j.jss.2026.08.036
Type
Peer-reviewed article
Design
Retrospective difference-in-differences cohort, National Cancer Database, 284,967 adults aged 40-64 with renal cell carcinoma, 2006-2021
Verdict
Confirms prior evidence
Driver
Cancer
Driver
Health systems and access
Free full text
Free copy in a repository (submitted manuscript)

Other drivers in Health today